Review
Published on 21 Aug 2024
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1394997
- 1,081 views
Type at least 3 characters
563 articles
Articles
Original Research
Published on 21 Aug 2024
Effects of Inonotus obliquus on ameliorating podocyte injury in ORG mice through TNF pathway and prediction of active compounds
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426917
- 845 views
Review
Published on 15 Aug 2024
Bibliometric analysis of research on retinoic acid in the field of kidney disorders
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1435889
- 919 views
- 1 citation
Original Research
Published on 06 Aug 2024
Women have a higher risk of hospital admission associated with hyponatremia than men while using diuretics
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409271
- 559 views
Original Research
Published on 01 Aug 2024
Association between PCSK9 inhibitors and acute kidney injury: a pharmacovigilance study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1353848
- 1,728 views
Original Research
Published on 01 Aug 2024
Piperazine ferulate inhibits diabetic nephropathy by suppressing AGE/RAGE-mediated inflammatory signaling in rats and podocytes
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1394369
- 1,042 views
Review
Published on 31 Jul 2024
A new perspective on proteinuria and drug therapy for diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1349022
- 1,998 views
- 1 citation
Original Research
Published on 29 Jul 2024
Angiotensin-II type 2 receptor-mediated renoprotection is independent of receptor Mas in obese Zucker rats fed high-sodium diet
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409313
- 927 views
Original Research
Published on 26 Jul 2024
Colquhounia root tablet improves diabetic kidney disease by regulating epithelial-mesenchymal transition via the PTEN/PI3K/AKT pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418588
- 775 views
- 1 citation
Review
Published on 25 Jul 2024
Opioids and the kidney: two sides of the same coin
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421248
- 977 views
Correction
Published on 23 Jul 2024
Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD–MBD model rats by targeting FGF23-Klotho signaling axis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446609
- 706 views
Review
Published on 22 Jul 2024
Investigating the value of urinary biomarkers in relation to lupus nephritis histopathology: present insights and future prospects
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421657
- 1,451 views
Systematic Review
Published on 19 Jul 2024
Effects and safety of Ophiocordyceps sinensis preparation in the adjuvant treatment for dialysis patients: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1360997
- 1,104 views
Original Research
Published on 17 Jul 2024
THSD7A-associated membranous nephropathy involves both complement-mediated and autonomous podocyte injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430451
- 1,209 views
Original Research
Published on 17 Jul 2024
The role of metabolic memory in diabetic kidney disease: identification of key genes and therapeutic targets
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1379821
- 1,415 views
Original Research
Published on 17 Jul 2024
Acrylamide-targeting renal miR−21a−5p/Fibrotic and miR122-5p/ inflammatory signaling pathways and the role of a green approach for nano-zinc detected via in silico and in vivo approaches
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413844
- 1,329 views